Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...

Fezolinetant (Veozah), the first of a new class of non-hormonal ... and Drug Administration in 2023 for the treatment of moderate to severe hot flashes. This class of drugs targets a specific ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Recent studies are helping researchers better understand the power of the mind-body connection in treating hot flashes.

"Last year, the FDA approved a new type of medication for the treatment of moderate to severe hot flashes called fezolinetant (brand name Veozah)," adds Nonacs. Minkin says that herbal remedies ...

Medications and natural remedies may also help treat hot flashes. Talk to your doctor before starting on any new medications or natural remedies. If you experience repeat hot flashes that don’t ...